You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sumitomo Dainippon Pharma Oncology SDPO

Showing 1 - 25 of 2,287
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial in Houston, Salt Lake City, Charlottesville (TP-3654)

Completed
  • Advanced Solid Tumors
  • Houston, Texas
  • +2 more
Apr 4, 2022

Advanced Solid Tumor, Advanced/ Metastatic Renal Cell Carcinoma (RCC), Microsatellite Iinstability-high (MSI-H) or Mismatch

Active, not recruiting
  • Advanced Solid Tumor
  • +3 more
  • TP-1454 monotherapy
  • TP-1454 combination therapy
  • Phoenix, Arizona
  • +8 more
Nov 18, 2022

Advanced Solid Tumors Trial in United States (TP-0184)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
Apr 4, 2022

Advanced Solid Tumors, Sarcoma Trial in United States (TP-1287)

Recruiting
  • Advanced Solid Tumors
  • Sarcoma
  • Los Angeles, California
  • +9 more
Apr 4, 2022

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia Trial in Columbus (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 4, 2022

Acute Myeloid Leukemia (AML) Trial in Germany, United Kingdom, United States (Venetoclax, Alvocidib)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +13 more
Jan 24, 2022

Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR

Completed
  • Healthy
  • Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
  • +2 more
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 2, 2023

High Grade Glioma, Glioblastoma Multiforme Trial in Japan, United States (DSP-0390)

Recruiting
  • High Grade Glioma
  • Glioblastoma Multiforme
  • San Francisco, California
  • +8 more
Dec 16, 2022

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in Japan, United States (DSP-5336)

Recruiting
  • Leukemia, Myeloid, Acute
  • Leukemia, Lymphocytic, Acute
  • Houston, Texas
  • +5 more
May 31, 2022

NSCLC Trial in United States (Napabucasin, Paclitaxel)

Terminated
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
Apr 4, 2022

Cancer, Advanced Malignancies Trial in Greenville, Ottawa, Montreal (BBI608)

Completed
  • Cancer, Advanced Malignancies
  • Greenville, South Carolina
  • +2 more
Apr 4, 2022

Schizophrenia Trial in Tokyo (DSP-5423P)

Completed
Has Results
  • Schizophrenia
  • Tokyo, Japan
    38 Sites
Apr 9, 2022

Glioblastoma, Diffuse Intrinsic Pontine Glioma Trial in Japan (DSP-7888)

Completed
  • Glioblastoma
  • Diffuse Intrinsic Pontine Glioma
  • Nagoya, Aichi, Japan
  • +5 more
Apr 9, 2022

ADME, Healthy Trial in Madison (napabucasin)

Completed
  • ADME
  • Healthy
  • Madison, Wisconsin
    Covance Clinical Research Unit
Apr 4, 2022

Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg

Active, not recruiting
  • Hypertension
  • Coronary Artery Disease
  • Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
  • Norvasc 5 mg tablets of Pfizer Labs
  • Vadodara, Gujarat, India
    Accutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Olivos, Buenos Aires, Argentina
  • +5 more
May 10, 2023

Bipolar I Disorder Trial in Worldwide (SM-13496)

Completed
Has Results
  • Bipolar I Disorder
  • Tokyo, Japan
  • +7 more
Apr 9, 2022

Drug-drug Interactions Trial in DeLand (napabucasin, cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate)

Completed
  • Drug-drug Interactions
  • napabucasin
  • cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate
  • DeLand, Florida
    Accel Research Sites
Apr 4, 2022

Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))

Completed
  • Healthy
  • Gleptomet 50/1000(Metformin HCl & Sitagliptin)
  • Janumet 50/1000(Metformin HCl & Sitagliptin)
  • Cairo, Egypt
    Genuine Research Center GRC
Mar 22, 2023

Urologic Malignancies, Renal Cell Carcinoma, Urothelial Carcinoma Trial (BBI503)

Withdrawn
  • Urologic Malignancies
  • +2 more
  • (no location specified)
Apr 4, 2022

Gastrointestinal Stromal Tumors Trial in Toronto (BBI503)

Terminated
  • Gastrointestinal Stromal Tumors
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 4, 2022

Healthy Volunteers Trial in Kistarcsa (BV100, Midazolam)

Recruiting
  • Healthy Volunteers
  • Kistarcsa, Hungary
    CRU Hungary Kft., Early Phase Unit
Sep 14, 2022

Hepatocellular Carcinoma, Cholangiocarcinoma Trial in Calgary, Ottawa, Toronto (BBI503)

Completed
  • Hepatocellular Carcinoma
  • Cholangiocarcinoma
  • Calgary, Alberta, Canada
  • +2 more
Apr 4, 2022